icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL 2017 - European Association for the
Study of the Liver
Amsterdam, The Netherlands. 2017
Back grey_arrow_rt.gif
 
 
 
Efficacy and Safety of Glecaprevir/Pibrentasvir in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection With and Without Cirrhosis
 
 
  Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
 
Kazuaki Chayama1, Fumitaka Suzuki2, Ken Sato3, Tomofumi Atarashi4, Tsunamasa Watanabe5, Hidenori Toyoda6, Masanori Atsukawa7, Atsushi Naganuma8,
Kazuo Notsumata9, Yukio Osaki10, Makoto Nakamuta11, Koichi Takaguchi12, Satoru Saito13, Koji Kato14, David L Pugatch14, Margaret Burroughs14, Rebecca Redman14, Katia Alves14, Tami J Pilot-Mati as14, Bo Fu14, Hiromitsu Kumada2
 
1Hiroshima University Hospital, Hiroshima, Japan; 2Toranomon Hospital, Tokyo, Japan; 3Gunma University Hospital, Maebashi, Japan; 4JA Hokkaido P.W.F.A.C Obihiro-Kosei General Hospital, Obihiro, Japan; 5St. Marianna University School of Medicine, Kawasaki, Japan; 6Ogaki Municipal Hospital, Ogaki, Japan; 7Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan; 8NHO Takasaki General Medical Center, Takasaki, Japan; 9Fukuiken Saiseikai Hospital, Fukui, Japan; 10Osaka Red Cross Hospital, Osaka, Japan; 11NHO Kyushu Medical Center, Fukuoka, Japan; 12Kagawa Prefectural Central Hospital, Takamatsu, Japan; 13Yokohama City University Hospital, Yokohama, Japan; 14AbbVie Inc., North Chicago, Illinois, United States

0501171

0501172

0501173

0501174

0501175

0501176

0501177

0501178